Marijuana Remains a Top Outlaw Drug Under U.S. Drug Enforcement Administration Ruling Today
A nine-year effort to get the government to reclassify marijuana as a drug with at least some legitimate uses ended in a FAIL today after the DEA just said no.
Pro-pot forces, however, say they'll appeal the decision to the U.S. Circuit Court in Washington.
As it stands, cannabis is still a top-level "Schedule 1" federal outlaw drug -- considered more illicit than even cocaine, which has some legit medical uses. Weed advocates were trying to get Washington to realize what we know here in Cali:
That pot has at least some medicinal uses.
UCLA Men's Soccer v Oregon State & UCLA Women's Soccer v Stanford
TicketsThu., Oct. 26, 4:30pm
CSUN Womens Soccer
TicketsThu., Oct. 26, 7:00pm
Los Angeles Lakers vs. Toronto Raptors
TicketsFri., Oct. 27, 7:30pm
UCLA Women's Soccer v California & UCLA Men's Soccer v Washington
TicketsSun., Oct. 29, 1:00pm
South Bay Lakers vs. Northern Arizona Suns
TicketsSun., Oct. 29, 7:00pm
But the 9-year-old petition for reclassification by the Coalition for Rescheduling Cannabis, including a recent lawsuit that prompted the DEA to get off its ass on this, was denied by the agency today.
The drug agency states that ...
... marijuana has a high potential for abuse, has no accepted medical use in the United States, and lacks an acceptable level of safety for use even under medical supervision.
The pro-pot troops, including Joe Elford, chief counsel of Americans for Safe Access, still have high hopes that the government will overcome is cannaphobia.
Although this superficially looks like a defeat for the medical marijuana community. It simply maintains the status quo. More importantly, however, we have foiled the government's strategy of delay and we can now go head-to-head on the merits, that marijuana really does have therapeutic value.
Get the ICYMI: Today's Top Stories Newsletter Our daily newsletter delivers quick clicks to keep you in the know
Catch up on the day's news and stay informed with our daily digest of the most popular news, music, food and arts stories in Los Angeles, delivered to your inbox Monday through Friday.